{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T04:08:04Z","timestamp":1749874084212,"version":"3.41.0"},"reference-count":74,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.2217\/imt-2016-0096","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T10:10:48Z","timestamp":1482315048000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Maintenance Immunosuppressants in the Management of Antibody-Mediated Renal Allograft Rejection: Which Regimen is Best?"],"prefix":"10.1080","volume":"9","author":[{"given":"Yiqun","family":"Zhou","sequence":"first","affiliation":[{"name":"Medical Department, Shanghai Roche Pharmaceuticals Ltd, Shanghai, 201203, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Li","sequence":"additional","affiliation":[{"name":"Medical Department, Shanghai Roche Pharmaceuticals Ltd, Shanghai, 201203, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[{"name":"Medical Department, Shanghai Roche Pharmaceuticals Ltd, Shanghai, 201203, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiquan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Renal Transplantation, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510530, China, xs"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,12,21]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02799.x"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03840.x"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302506"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00332.x"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2005.00261.x"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04013.x"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01613.x"},{"key":"e_1_3_3_9_1","first-page":"11","volume-title":"The 2016 American Transplant Congress","author":"Choi J","year":"2016","unstructured":"Choi J , VoA, HaasMet al. Anti-IL6R therapy (tocilizumab) improves long-term patient & graft survival in patients with chronic antibody-mediated rejection and transplant glomerulopathy (abstract). Presented at: The 2016 American Transplant Congress. Boston, MA, USA, 11\u201315June2016 (Abstract 1885)."},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2011.08.015"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp110624"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12786"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.437"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04291.x"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw027"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000145878.92906.9F"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00360.x"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31827d62e3"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13341"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31817fdddb"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001552"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/845040"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-003-0139-x"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199812150-00008"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001870"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(00)00188-0"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02612.x"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002003"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014060588"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg304"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12596"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404683"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000031"},{"key":"e_1_3_3_34_1","first-page":"323","article-title":"Post-transplant donor-specific antibody production and graft outcome in kidney transplantation: results of sixteen-year monitoring by flow cytometry","author":"Piazza A","year":"2006","unstructured":"Piazza A , PoggiE, OzzellaGet al. Post-transplant donor-specific antibody production and graft outcome in kidney transplantation: results of sixteen-year monitoring by flow cytometry. Clin. Transpl.323\u2013336 (2006).","journal-title":"Clin. Transpl."},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04251.x"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03961.x"},{"key":"e_1_3_3_37_1","first-page":"247","article-title":"Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation","author":"Huang Y","year":"2012","unstructured":"Huang Y , RamonD, LuanFL, SungR, SamaniegoM. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation. Clin. Transpl.247\u2013256 (2012).","journal-title":"Clin. Transpl."},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000186390.10150.66"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfk027"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200107150-00016"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V131242"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-006-0531-3"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31820d3b9b"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02668.x"},{"key":"e_1_3_3_45_1","unstructured":"Karam G K\u00e4lbleT AlcarazAet al. Guidelines on renal transplantation (2009).http:\/\/uroweb.org\/wp-content\/uploads\/27-Renal-Transplant_LRV2-May-13th-2014.pdf."},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.2165\/11538530-000000000-00000"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.04051.x"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(99)00732-0"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199704150-00013"},{"key":"e_1_3_3_50_1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1399-0012.1997.tb00814.x","article-title":"Reversal of accelerated renal allograft rejection with FK 506","volume":"11","author":"Woodle ES","year":"1997","unstructured":"Woodle ES , NewellKA, HaasMet al. Reversal of accelerated renal allograft rejection with FK 506. Clin. Transplant.11, 251\u2013254 (1997).","journal-title":"Clin. Transplant."},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/750602"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V12suppl_1s48"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181e065de"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.889536"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181874a36"},{"key":"e_1_3_3_56_1","first-page":"405","article-title":"Comparative analysis of drug action on B-cell proliferation and differentiation for mycophenolic acid, everolimus, and prednisolone","volume":"97","author":"Haneda M","year":"2014","unstructured":"Haneda M , OwakiM, KuzuyaT, IwasakiK, MiwaY, KobayashiT. Comparative analysis of drug action on B-cell proliferation and differentiation for mycophenolic acid, everolimus, and prednisolone. Transplantation97, 405\u2013412 (2014).","journal-title":"Transplantation"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2010.11.001"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12330"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02615.x"},{"key":"e_1_3_3_60_1","first-page":"18","volume-title":"2013 American Transplant Congress","author":"Budde K","year":"2013","unstructured":"Budde K , ArnsW, SommererCet al. Superior renal function in an everolimus-based calcineurin inhibitor free regimen compared with standard cyclosporine\/mycophenolate and low cyclosporine\/everolimus: follow-up of the HERAKLES study at month 24. Presented at: 2013 American Transplant Congress. Seattle, WA, USA, 18\u201322May2013 (Abstract B932)."},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2012.01432.x"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.10.57"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12526"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12721"},{"key":"e_1_3_3_65_1","first-page":"CD010699","article-title":"Belatacept for kidney transplant recipients","volume":"11","author":"Masson P","year":"2014","unstructured":"Masson P , HendersonL, ChapmanJR, CraigJC, WebsterAC. Belatacept for kidney transplant recipients. Cochrane Database Syst. Rev.11, CD010699 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.03005.x"},{"key":"e_1_3_3_67_1","first-page":"2","volume-title":"2015 American Transplant Congress","author":"Bray R","year":"2015","unstructured":"Bray R , GebelH, TownsendR, Meier-KriescheU, LarsenC. Evaluation of donor-specific antibodies through 7 years with belatacept in BENEFIT and BENEFIT-EXT. Presented at: 2015 American Transplant Congress. Philadelphia, PA, USA, 2\u20136May2015 (Abstract 458)."},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506027"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2011.01223.x"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03914.x"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01259.x"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054621"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2006.00444.x"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986730607220401123549"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.10.015"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2016-0096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T20:04:49Z","timestamp":1749845089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2016-0096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,21]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.2217\/imt-2016-0096"],"URL":"https:\/\/doi.org\/10.2217\/imt-2016-0096","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"type":"print","value":"1750-743X"},{"type":"electronic","value":"1750-7448"}],"subject":[],"published":{"date-parts":[[2016,12,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-08-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-10-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-12-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}